Government Briefs

Don’t Touch That Money! The embattled U.S. Agency for International Development malaria vaccine research project (The Scientist, July 10, 1989, page 1; Oct. 16, 1989, page 12) received another blow last month with the release of a government report that condemns the manner in which AID has managed the $100 million effort. The problems are so extensive, says the General Accounting Office, that AID officials should postpone any plans to build a $15 million field testing station in the Sout

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The embattled U.S. Agency for International Development malaria vaccine research project (The Scientist, July 10, 1989, page 1; Oct. 16, 1989, page 12) received another blow last month with the release of a government report that condemns the manner in which AID has managed the $100 million effort. The problems are so extensive, says the General Accounting Office, that AID officials should postpone any plans to build a $15 million field testing station in the South Pacific until the Institute of Medicine has conducted an extensive review of the status of malarial research around the world. The GAO report criticizes all aspects of the project, begun in 1974 and fueled by periodic announcements that a vaccine was just around the corner. Among its many faults, AID is attacked for bungling the research by: funding two projects that received negative evaluations in a scientific review; awarding 10 of 11 research contracts ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies